Sorry, you need to enable JavaScript to visit this website.

Our Policies on Ethics

As we work to develop new medicines, our strict standards of moral and ethical conduct are guided by the help and oversight of institutional review boards, regulatory authorities, and industry association guidelines governing ethical clinical trial conduct and research integrity.

All Pfizer-sponsored interventional studies are conducted in accordance with applicable laws and regulations, as well as principles derived from relevant international standards including:

  • The Council for International Organizations of Medical Sciences (CIOMS) International Ethical Guidelines

  • The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) E6 guideline for Good Clinical Practice

  • PhRMA’s Principles on Conduct of Clinical Trials and Communication of Clinical Trial Results

  • The Declaration of Helsinki

  • The United States Belmont report

We strive to maintain the highest ethical, scientific, and clinical standards in all our clinical research around the world. We regularly review our policies to align them with Pfizer's vision, values, and goals, and with our stakeholders' evolving priorities.

Related Articles

8 Lessons I’ve Learned as a Cancer Survivor

After a rare cancer diagnosis, Pfizer scientist Isis Kanevsky shares the lessons that ground her as she navigates treatment and survivorship.

Collage of a smiling woman with her dog and young girl in outdoor and indoor scenes

Then vs. Now: Flow Chemistry

The way medicines are made has changed significantly over time. Many of today’s drug molecules are larger and more complex than those developed decades ago and the methods for synthesis have evolved accordingly. As chemists design increasingly sophisticated molecules, they also need more precise and flexible ways to carry out the reactions that produce them.

Photograph of a scientist in a lab coat working with glassware in a laboratory thumbnail

Then vs. Now: Molecular Design

Developing a new medicine starts at the most fundamental level: understanding how disease works. That often means looking beyond what we can observe directly and studying how molecules interact with biological targets.

Black-and-white photo of a scientist holding a wireframe molecular model

Clinical Trials

We proudly partner with thousands of study sites and tens of thousands of trial participants around the world. It’s these clinical trials that lead to life-changing medicines.

Go to Pfizer Clinical Trials Site Details